MaterialsChaumontel, Ile-de-France, FranceFounded 2014· One of 970 Materials companies tracked by AMPulse
French materials company developing patented high-performance titanium and titanium-ceramic composite powders for metal additive manufacturing (medical and aerospace).
CEO / Founder
Madjid Djemai
Team Size
1-10
Stage
Defunct
Latest Round
Grant
Key Investors
French National Research Agency; HS HI-TECH
Technology & Products
Key Products
ZTi-Powder, ZTi-Med
Technological Advantage
Improved ductility, wear resistance and heat oxidation compared to traditional alloys.
Differentiation
Value Proposition
Develops patented nano-structured titanium-zirconia powders and advanced Ti alloys (ZTM14N, ZTP10, ZTP20Z) with improved ductility, wear resistance, oxidation resistance, and bone-matching elasticity for AM medical and aerospace parts.
How They Differentiate
Titanium zirconium alloy powders designed to replace existing alloys in critical engineering and medical additive manufacturing applications.
Market & Competition
Target Customers
Medical implant and aerospace additive manufacturing users (OEMs, implant makers, AM service bureaus)
Industry Verticals
Aeronautics, Medical
Competitors
Sintavia; Stratasys; Metalysis
Growth & Milestones
Growth Metrics
Participates in ANR project OPTIMAA with LSPM (project ID ANR-23-LCV2-0002, ongoing as of 2023).
Major Milestones
Partnership with 6K Additive, Development of ZTi-Powder and ZTi-Med materials
Z3Dlab positions itself as a materials specialist in metal additive manufacturing, focusing on titanium-zirconium alloy powders that aim to replace conventional alloys in demanding applications. Founded in 2014 and based in Chaumontel, France, the company competes in the LPBF materials segment, ranking 50th among 114 active competitors.
The company's core products are ZTi-Powder and ZTi-Med, patented titanium-ceramic composite powders designed for laser powder bed fusion. These materials claim improved ductility, wear resistance, and heat oxidation performance compared to traditional titanium alloys. The powders target two primary verticals: aeronautics and medical devices.
In the medical space, Z3Dlab focuses on engineered bone implants that are biocompatible, durable, and customizable for patient-specific bone defects. The company has partnered with 6K Additive, a notable customer and partner, to scale production and distribution. It also participates in the ANR project OPTIMAA with LSPM, a research collaboration ongoing as of 2023.
Z3Dlab has raised $10.7 million from investors including the French National Research Agency and HS HI-TECH. CEO Madjid Djemai brings two decades of energy-sector experience across multiple continents. The company's main competitive risk lies in the narrow adoption of its proprietary powders versus established Ti-6Al-4V grades, which dominate medical and aerospace LPBF applications.